Aapro MS - Search Results

1

Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.

Aapro MS. Aapro MS. Oncology (Williston Park). 1997 Aug;11(8 Suppl 8):46-9. Oncology (Williston Park). 1997. PMID: 9364543 Review.

2

Early clinical studies with docetaxel. Docetaxel Investigators Group.

Aapro M, Bruno R. Aapro M, et al. Eur J Cancer. 1995;31A Suppl 4:S7-10. doi: 10.1016/0959-8049(95)00360-u. Eur J Cancer. 1995. PMID: 7577102 Review.

3

Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer.

Michel G, Leyvraz S, Bauer J, Aapro M, Stahel R, Alberto P. Michel G, et al. Ann Oncol. 1994 Apr;5(4):369-70. doi: 10.1093/oxfordjournals.annonc.a058844. Ann Oncol. 1994. PMID: 8075036 Free article. Clinical Trial.

4

Advances in systemic treatment of malignant melanoma.

Aapro MS. Aapro MS. Eur J Cancer. 1993;29A(4):613-7. doi: 10.1016/s0959-8049(05)80164-9. Eur J Cancer. 1993. PMID: 8435218 Review.

5

Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.

Nolè F, de Braud F, Aapro M, Minchella I, De Pas TM, Zampino MG, Monti S, Andreoni G, Goldhirsch A. Nolè F, et al. Ann Oncol. 1997 Sep;8(9):865-70. doi: 10.1023/a:1008209429204. Ann Oncol. 1997. PMID: 9358936 Free article. Clinical Trial.

6

Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.

Nabholtz JM, Thuerlimann B, Bezwoda WR, Melnychuk D, Deschênes L, Douma J, Vandenberg TA, Rapoport B, Rosso R, Trillet-Lenoir V, Drbal J, Aapro MS, Alaki M, Murawsky M, Riva A. Nabholtz JM, et al. Among authors: aapro ms. Oncology (Williston Park). 1997 Aug;11(8 Suppl 8):25-30. Oncology (Williston Park). 1997. PMID: 9364538 Free article. Clinical Trial.

7

Breast cancer.

Aapro M, Piccart M. Aapro M, et al. Crit Rev Oncol Hematol. 1998 Feb;27(2):135-7. doi: 10.1016/s1040-8428(97)10021-x. Crit Rev Oncol Hematol. 1998. PMID: 9571316 Review. No abstract available.

8

Docetaxel versus doxorubicin in patients with metastatic breast cancer who have failed alkylating chemotherapy: a preliminary report of the randomized phase III trial. 303 Study Group.

Aapro M. Aapro M. Semin Oncol. 1998 Oct;25(5 Suppl 12):7-11. Semin Oncol. 1998. PMID: 9865705 Clinical Trial.

9

Combining new agents with anthracyclines in metastatic breast cancer: an overview of recent findings.

Aapro MS. Aapro MS. Semin Oncol. 1999 Feb;26(1 Suppl 3):17-21. Semin Oncol. 1999. PMID: 10203266 Review.

10

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

Nabholtz JM, Senn HJ, Bezwoda WR, Melnychuk D, Deschênes L, Douma J, Vandenberg TA, Rapoport B, Rosso R, Trillet-Lenoir V, Drbal J, Molino A, Nortier JW, Richel DJ, Nagykalnai T, Siedlecki P, Wilking N, Genot JY, Hupperets PS, Pannuti F, Skarlos D, Tomiak EM, Murawsky M, Alakl M, Aapro M, et al. Nabholtz JM, et al. J Clin Oncol. 1999 May;17(5):1413-24. doi: 10.1200/JCO.1999.17.5.1413. J Clin Oncol. 1999. PMID: 10334526 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters